On Monday, Larimar Therapeutics Inc (NASDAQ: LRMR) opened higher 3.31% from the last session, before settling in for the closing price of $1.81. Price fluctuations for LRMR have ranged from $1.61 to $11.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -38.94% at the time writing. With a float of $36.59 million, this company’s outstanding shares have now reached $63.82 million.
The firm has a total of 65 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Larimar Therapeutics Inc (LRMR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Larimar Therapeutics Inc is 42.86%, while institutional ownership is 59.05%.
Larimar Therapeutics Inc (LRMR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -38.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.48% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Check out the current performance indicators for Larimar Therapeutics Inc (LRMR). In the past quarter, the stock posted a quick ratio of 8.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -2.04 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Analysing the last 5-days average volume posted by the [Larimar Therapeutics Inc, LRMR], we can find that recorded value of 0.91 million was better than the volume posted last year of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 34.71%. Additionally, its Average True Range was 0.21.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 4.91%, which indicates a significant decrease from 31.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.66% in the past 14 days, which was higher than the 85.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7166, while its 200-day Moving Average is $5.8005. Now, the first resistance to watch is $1.9083. This is followed by the second major resistance level at $1.9467. The third major resistance level sits at $1.9933. If the price goes on to break the first support level at $1.8233, it is likely to go to the next support level at $1.7767. Now, if the price goes above the second support level, the third support stands at $1.7383.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
There are currently 64,028K shares outstanding in the company with a market cap of 119.74 million. Presently, the company’s annual sales total 0 K according to its annual income of -80,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -28,820 K.
